The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation between toxicity and outcome after multimodality therapy of locoregionally advanced (LRA) adenocarcinoma (ACA) of the esophagus (E) and gastroesophageal junction (GEJ).
Kwabena Osei-Boateng
No relevant relationships to disclose
Lisa A. Rybicki
No relevant relationships to disclose
Thomas W. Rice
No relevant relationships to disclose
Cristina P. Rodriguez
No relevant relationships to disclose
Gregory M.M. Videtic
No relevant relationships to disclose
Jerrold P. Saxton
No relevant relationships to disclose
Michael J. McNamara
No relevant relationships to disclose
Denise I. Ives
No relevant relationships to disclose
Joanna Bodmann
No relevant relationships to disclose
David J. Adelstein
Research Funding - AstraZeneca; GlaxoSmithKline; Sanofi